Showing results (191-200 of 238) with videos related to
Sort By:
Pageof 24
Movement Disorders : Official Journal of the Movement Disorder Society|May 10, 2024
Triheptanoin Did Not Show Benefit versus Placebo for the Treatment of Paroxysmal Movement Disorders in Glut1 Deficiency Syndrome: Results of a Randomized Phase 3 StudyValentina De Giorgis, Kailash P Bhatia, Odile Boespflug-Tanguy, et al.Blood|March 8, 2012
Identification of an active, well-tolerated dose of pralatrexate in patients with relapsed or refractory cutaneous T-cell lymphomaSteven M Horwitz, Youn H Kim, Francine Foss, et al.The Journal of Infectious Diseases|October 9, 1999
Potent induction of focused Th1-type cellular and humoral immune responses by RTS,S/SBAS2, a recombinant Plasmodium falciparum malaria vaccineA Lalvani, P Moris, G Voss, et al.Journal of Virology|August 10, 2018
Adjuvant-Dependent Enhancement of HIV Env-Specific Antibody Responses in Infant Rhesus MacaquesBonnie Phillips, Koen K A Van Rompay, Jennifer Rodriguez-Nieves, et al.Current Opinion in Virology|February 1, 2016
Selection of HIV vaccine candidates for concurrent testing in an efficacy trialYing Huang, Carlos DiazGranados, Holly Janes, et al.Journal of Virology|July 30, 2005
Human immunodeficiency virus type 1 env clones from acute and early subtype B infections for standardized assessments of vaccine-elicited neutralizing antibodiesMing Li, Feng Gao, John R Mascola, et al.Cancers|January 11, 2024
Digging into the NGS Information from a Large-Scale South European Population with Metastatic/Unresectable Pancreatic Ductal Adenocarcinoma: A Real-World Genomic DepictionDimitrios C Ziogas, Eirini Papadopoulou, Helen Gogas, et al.Vaccine|October 20, 2006
Durable HIV-1 antibody and T-cell responses elicited by an adjuvanted multi-protein recombinant vaccine in uninfected human volunteersPaul A Goepfert, Georgia D Tomaras, Helen Horton, et al.Expert Review of Pharmacoeconomics & Outcomes Research|November 13, 2018
Patterns of practice and pharmacoeconomic analysis of the management of patients with metastatic renal cell carcinoma (mRCC) in Greece--the CRISIS study. A retrospective analysis by the Hellenic Genitourinary Cancer Group (HGUCG)Georgiops Tsironis, Konstantinos Koutsoukos, Konstantinos Athanasakis, et al.Journal of Acquired Immune Deficiency Syndromes (1999)|October 4, 2011
Induction of strong HIV-1-specific CD4+ T-cell responses using an HIV-1 gp120/NefTat vaccine adjuvanted with AS02A in antiretroviral-treated HIV-1-infected individualsMathias Lichterfeld, Rajesh T Gandhi, Rachel P Simmons, et al.Pageof 24